N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors

被引：6
|
作者：
Garcia, Gonzalo [1 ]
Abet, Valentina [1 ]
Alajarin, Ramon [1 ]
Alvarez-Builla, Julio [1 ]
Delgado, Mercedes [2 ]
Garcia-Garcia, Luis [2 ]
Bascunana-Almarcha, Pablo [2 ]
Pena-Salcedo, Carmen [3 ]
Kelly, James [3 ]
Pozo, Miguel A. [2 ,3 ]
机构：
[1] Univ Alcala, Dept Quim Organ, Madrid 28871, Spain
[2] Inst Pluridisciplinar UCM, CAI Cartog Cerebral, Madrid 28040, Spain
[3] Inst Tecnol PET, Madrid 28040, Spain
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 85卷
关键词：
5-HT1A; Positron emission tomography; Fluorine-18; Radioligand; N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides; NUCLEOPHILIC AROMATIC-SUBSTITUTION; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; RADIOACTIVE METABOLITES; TISSUE DISTRIBUTION; ARYL HALIDES; HUMAN PLASMA; BRAIN; WAY-100635; RADIOLIGAND;
D O I：
10.1016/j.ejmech.2014.07.096
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides were prepared by labeling their 4-nitropyridin-2-yl precursors through nitro substitution by the F-18 anion. In vitro and in vivo tests showed that the cyclohexanecarboxamide derivative is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, k(i) = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional standards. This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码：795 / 806
页数：12
相关论文
共 50 条
  • [11] Synthesis and preliminary in vivo evaluation of 4[18F]fluoro-N-{2-[4-(6-trifluoromethylpyridin-2-yl) piperazin-1-yl]ethyl}benzamide, a potential PET radioligand for the 5-HT1A receptor
    Vandecapelle, M
    Dumont, F
    De Vos, F
    Strijckmans, K
    Leysen, D
    Audenaert, K
    Dierckx, RA
    Slegers, G
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2004, 47 (09): : 531 - 542
  • [12] Synthesis of (E)-4, 3, 2-[11C]methoxy-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)cinnamoylamides and (E)-4, 3, 2-[18F]fluoron-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-cinnamoylamides as new potential pet dopamine D2 and D3 receptor ligands.
    Gao, M
    Wang, JQ
    Zheng, QH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U114 - U114
  • [13] Substitution mode of the amide fragment in some new N-{ω-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity
    Paluchowska, MH
    Bugno, R
    Charakchieva-Minol, S
    Bojarski, AJ
    Wesolowska, A
    POLISH JOURNAL OF PHARMACOLOGY, 2001, 53 (04): : 369 - 376
  • [14] An Efficient Synthesis of trans-N-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-N-(2-pyridy1)-N-(4-tosyloxymethylcyclohexane)carboxamide, A Precursor of [18F]Mefway for Imaging 5-HT1A Receptor
    Choi, Jae Yong
    Kim, Chul Hoon
    Kim, Jung Young
    Ha, Hyun-Joon
    Ryu, Young Hoon
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2010, 31 (08) : 2371 - 2374
  • [15] Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine
    Zoidis, Grigoris
    Isabel Loza, Maria
    Catto, Marco
    MOLBANK, 2022, 2022 (01)
  • [16] N-[(R)-(6-Bromo-2-methoxyquinolin-3-yl)(phenyl)methyl]-N-[(S)-1-(4-methoxyphenyl)ethyl]-2-(piperazin-1-yl)acetamide
    Yuan, Lei
    Wang, Rui
    Li, Chang-Yi
    Wang, Zhi-Qiang
    Sun, Tie-Min
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2921 - U365
  • [17] Synthesis, Crystal Structure and Biological Activity of N-(2-hydroxy-3-(4-(2-methoxyphenyl)-piperazin-1-yl)propyl)quinoxaline-2-methanamide
    Huang Min-Yi
    Xu Wei
    Huang Jun-Jun
    Huang Ya-Jian
    Yuan Mu
    CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2015, 34 (04) : 497 - 502
  • [18] Synthesis, Crystal Structure and Biological Activity of N-(2-hydroxy-3-(4-(2-methoxyphenyl)-piperazin-1-yl)propyl)quinoxaline-2-methanamide
    黄敏怡
    徐未
    黄珺珺
    黄亚建
    袁牧
    结构化学, 2015, 34 (04) : 497 - 502
  • [19] Predicting dopamine D3 receptor binding affinity of n-(ω-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides:: Computational approach using topological descriptors
    Lather, V
    Madan, AK
    MATCH-COMMUNICATIONS IN MATHEMATICAL AND IN COMPUTER CHEMISTRY, 2004, (52) : 65 - 89
  • [20] N-{(2Z)-4-[4-(3-chlorophenyl)piperazin-1-yl]but-2-enyl}-1,8-naphthalimide
    Kowalska, Teresa
    Kowalski, Piotr
    MOLBANK, 2005, (03)
12345